Journals / Fırat Tıp Dergisi / 2010 / Cilt: 15 - Sayı: 1

The relationship of Ki-67 proliferation index, p53 expression, AgNOR number and prognostic factors in kidney's renal cell carcinomas with histopathological type and grading

Böbreğin renal hücreli karsinomlarında Ki-67 proliferasyon indeksi, p53 expresyonu, AgNOR sayısı ve prognostik faktörlerin, histopatolojik tip ve derecelendirme ile ilişkisi

Pages
34–39
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Ki-67 PI was determined to be 4.55% in transparent RCC, 3,33% in granular RCC, 3,66%in chromoplobe RCC, 28,7% in fusiform cell carcinoma,0,3% in cystic RCC, and it was found out that Ki-67 PI displayed differences according to histopathological types in renal cell carnicomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Renal cell carcinomas, the most common malignant kidney tumor, ranks third among urological tumors.
📊
Key Findings & Data:In this study, in the samples prepared by nephrectomy materials belonging to incidents with renal cell carcinoma, by comparing P53 ve Ki-67 immunohistochemically, AgNOR's chromophobe qualities histochemically, it was aimed to evaluate the benefit of them as prognostic criteria.
💡
Conclusion & Impact:Results: Ki-67 PI was determined to be 4.55% in transparent RCC, 3,33% in granular RCC, 3,66%in chromoplobe RCC, 28,7% in fusiform cell carcinoma,0,3% in cystic RCC, and it was found out that Ki-67 PI displayed differences according to histopathological types in renal cell carnicomas.
🔬Design:Research Article
📍Scope:2002 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Renal cell carcinomas, the most common malignant kidney tumor, ranks third among urological tumors. The patients with renal cell carcinoma usually have bad prognosis. In this study, in the samples prepared by nephrectomy materials belonging to incidents with renal cell carcinoma, by comparing P53 ve Ki-67 immunohistochemically, AgNOR's chromophobe qualities histochemically, it was aimed to evaluate the benefit of them as prognostic criteria. Materials and Methods: Nephrectomy materials diagnosed with renal cell carnicoma were taken into study between 1994 and 2002 in our department. Sections of 54 incidents were looked into and diagnoses were confirmed. Prognostic factors were re-evaluated. Ki-67 P53 and AgNOR chromophobe methods were applied to the prepared sections as immunohistochemically. Results: Ki-67 PI was determined to be 4.55% in transparent RCC, 3,33% in granular RCC, 3,66%in chromoplobe RCC, 28,7% in fusiform cell carcinoma,0,3% in cystic RCC, and it was found out that Ki-67 PI displayed differences according to histopathological types in renal cell carnicomas. There was a significant difference between PI of fusiform RCC and PI of other types of RCC (p<0.001). Conclusion: In conclusion, we decided to that the parameters as prognostic factors, because of studies showing differences between the reliability in determining the prognosis was not enough.

Özet

Amaç: En sık görülen malign böbrek tümörü olan renal hücreli karsinomlar, ürolojik tümörler içerisinde 3. sıradadır. Renal hücreli karsinomu olan hastalar genellikle kötü prognoza sahiptir. Bu çalışmamızda, renal hücreli karsinomlu olgulara ait nefrektomi materyallerinden hazırlanan örneklerde, immünhistokimyasal olarak P53 ve Ki-67, histokimyasal olarak AgNOR'un boyanma özelliklerini karşılaştırarak, bunların prognostik kriterler olarak yararının değerlendirilmesi amaçlandı. Gereç ve Yöntemler: 1994-2002 yılları arasında Renal hücreli karsinom tanısı alan nefrektomi materyalleri çalışmaya alındı. Toplam 54 olgunun tanıları doğrulandı. Prognostik faktörler yeniden değerlendirildi. İmmünohistokimyasal olarak Ki-67, P53 ve AgNOR boyama yöntemi uygulandı. Bulgular: Ki-67 PI şeffaf RCC'de %4.55, granüler RCC'de %3.33, kromofob RCC'de %3.66, iğsi hücreli karsinomda %28.7, kistik RCC'de %0.3 olarak belirlendi ve Ki-67 PI'nin renal hücreli karsinomlarda histopatolojik tiplere göre değişiklikler gösterdiği saptandı. İğsi RCC'nin PI'si ile diğer tip RCC'lerin PI'leri arasında anlamlı bir farklılık bulunmaktaydı (P<0.001). Diğer gruplar arasında bulgular benzerdi. Ki-67 PI şeffaf RCC'de %4.55, granüler RCC'de %3.33, kromofob RCC'de %3.66, iğsi hücreli karsinomda %28.7, kistik RCC'de %0.3 olarak belirlendi ve Ki-67 PI'nin renal hücreli karsinomlarda histopatolojik tiplere göre değişiklikler gösterdiği saptandı. İğsi RCC'nin PI'si ile diğer tip RCC'lerin PI'leri arasında anlamlı bir farklılık bulunmaktaydı (P<0.001). Sonuç: Prognostik faktör olarak belirtilen parametrelerin, çalışmalar arasında farklılıklar göstermesi nedeniyle prognozu belirlemede güvenilirliklerinin yeterli olmadığına karar verilmiştir.

🔖

Cite This Article

SOLMAZ, Ö. A., YEKELER, H. (2010). The relationship of Ki-67 proliferation index, p53 expression, AgNOR number and prognostic factors in kidney's renal cell carcinomas with histopathological type and grading. Fırat Tıp Dergisi, Cilt: 15 - Sayı: 1, 34–39. https://ajindex.com/articles/223672

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Papadopoulos I,Rudolph P, Weichert-Jacopsen K.Value of p53 Expression, Cellular Proliferation, and DNA Content as Prognostic Indicators in Renal Cell Carcinoma. Eur Urol 1997; 32:110-117
  2. Papadopoulos I, Weichert-Jacobsen K, Sprenger E, Wacker H.H. DNA Content and the Proliferation Marker Ki-67 as Prognostic İndicators in Renal Cell Carcinoma.Urol Int 1994; 53:181-185
  3. Ordonez NG, Rosai J. Ürinary tract. Rosai J (editör). Ackerman's Surgical Pathology. Eighth Edition, St. Louis: Missouri: Mosby Year Book Inc, 1996: 1059-1184
  4. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K. Prognostic Value of Ki-67 Expression in Renal Cell Carcinoma. Eur Urol 1997;31:350-355
  5. Shımazuı T, Tomobe M, Hattorı K, Uchida K, Akaza H, Koıso K. A Prognostic Sıgnıfıcance Of Nucleolar Organizer Region (AgNOR) In Renal Cell Carcinoma. J Urol 1995;154:1522-1526
  6. Visapaa H, Bui M, Huang Y at al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal cell carcinoma. Urology 2003; 61: 845-850
  7. Lang H, Jacqmin D. Prognostic factors in renal cell carcinoma. EAU Update series. 2003; 1: 215-219
  8. De la Taille A, Buttyan R, Katz AE at al. Biomarkers of renal cell carcinoma past and future considerations. Urol Oncol 2000; 5: 139-148
  9. Yasunaga Y, Shin M, Miki T, Okuyama A, Aozasa K. Prognostic factors of renal cell carcinoma: a multivariate analysis. J surg oncol 1998; 68: 11-18
  10. Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Seminn diagn pathol 1998;15: 68-76
  11. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. Cancer 2000; 89: 604-614
  12. Bugert P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 1996; 149: 2081-2088
  13. Bostwick D, Eble J, Denis L, Murphy G, Von Eschenbach A. Diagnosis and prognosis of renal cell carcinoma. Cancer 1997;80: 973-1001
  14. Girgin C, Tahran H, Hekimgil M, Sezer A, Gürel G. P53 Mutations and Other Prognostic Factors of Renal Cell Carcinoma. Urol Int 2001; 66: 78-83
  15. Goldstein NS. Grading of renal cell carcinoma. Urol Clin Nort Am 1999; 26: 637-642
  16. Gelb AB, Sudilovsky D, Wu DC, Weiss LM, Mederios LJ. Appraisal of İntratumoral Microvessel Density, MIB-1 Score, DNA Content and p53 Protein Expression as Prognostic Indicators in Patients with Locally Confined Renal Cell